These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15632859)

  • 1. Isolated mediastinal skip metastasis in lung cancer: is it real N2 disease?
    Puma F
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):235. PubMed ID: 15632859
    [No Abstract]   [Full Text] [Related]  

  • 2. Resection of lung carcinomas invading the mediastinum, including the superior vena cava.
    Grunenwald DH
    Thorac Surg Clin; 2004 May; 14(2):255-63, vii. PubMed ID: 15382301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer].
    Wang S; Wu Y; Ou W
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):259-61. PubMed ID: 11783103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is primary resection of stage IIIA lung cancer futile?
    Grannis FW
    Ann Thorac Surg; 2008 Jul; 86(1):353-4; author reply 354. PubMed ID: 18573468
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single station N2 NSCLC: a brief reflection on possible overdoing.
    Cafarotti S; Cesario A; Cusumano G; Granone P
    Ann Thorac Surg; 2009 Dec; 88(6):2069-70; author reply 2070. PubMed ID: 19932304
    [No Abstract]   [Full Text] [Related]  

  • 10. Final results after pneumonectomy for non-small cell lung cancer.
    Dalton ML; Clericuzio CP
    Curr Surg; 2005; 62(5):509-11. PubMed ID: 16125608
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
    Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion.
    Sakakura N; Mori S; Okuda K; Fukui T; Hatooka S; Shinoda M; Matsuo K; Yatabe Y; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1084-90. PubMed ID: 18805136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited commentary.
    Pelosi G; Rosai J
    Ann Thorac Surg; 2008 Oct; 86(4):1090-1. PubMed ID: 18805137
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
    Ilic N; Petricevic A; Arar D; Kotarac S; Banovic J; Ilic NF; Tripkovic A; Grandic L
    J Thorac Oncol; 2007 Nov; 2(11):1018-21. PubMed ID: 17975493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
    Casali C; Stefani A; Natali P; Rossi G; Morandi U
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.